Please Wait.....
Report
Dermatological Therapeutics Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Application (Alopecia, Herpes, Psoriasis, Rosacea, Atopic Dermatitis, Others), By Drug Class (Anti-infectives, Corticosteroids, Anti-acne, Calcineurin Inhibitors, Retinoids, Others), By Region, & Competition, 2020-2030F
Market Report I 2025-04-25 I 182 Pages I TechSci Research
Market Overview
The Dermatological Therapeutics Market was valued at USD 21.80 billion in 2024 and is projected to reach USD 35.25 billion by 2030, growing at a CAGR of 8.30%. This market encompasses the diagnosis and treatment of conditions affecting the skin, hair, nails, and mucous membranes, including common ailments like acne and eczema, as well as serious diseases such as psoriasis and skin cancer. Demand for dermatological treatments is rising due to the growing prevalence of skin disorders, increasing awareness around skin health, and technological advances in biologics and personalized medicine. As the global population ages and aesthetic concerns gain prominence, the market is experiencing heightened interest in both medical and cosmetic skin therapies. Expanding disposable incomes, particularly in emerging markets, are also enabling broader access to dermatological care. Pharmaceutical innovations and digital health trends are poised to reshape how dermatological conditions are diagnosed and managed, driving sustained growth in the sector.
Key Market Drivers
Rising Prevalence of Skin Disorders
The increasing global burden of skin diseases is a primary driver of the Dermatological Therapeutics Market. Skin disorders affect approximately 1.8 billion people worldwide, with estimates suggesting that 30% to 70% of the population experiences some form of dermatological condition at any given time. This widespread prevalence underscores a strong, sustained demand for effective skin treatments. Common conditions such as acne, eczema, psoriasis, atopic dermatitis, rosacea, and various infections are becoming more frequent across all age groups. This expanding patient pool presents a significant opportunity for pharmaceutical companies to develop and market innovative dermatological solutions. Additionally, growing awareness of skin health, driven by social media and increasing focus on aesthetics, further boosts demand for both therapeutic and cosmetic dermatology products. The persistent rise in skin disease incidence makes dermatology one of the most essential and dynamic sectors in healthcare, reinforcing its critical role in global medical infrastructure.
Key Market Challenges
Generic Competition
Generic competition poses a significant challenge to branded pharmaceutical companies operating in the dermatological therapeutics space. Once the patent protection for a drug expires, generic alternatives enter the market, often at significantly lower prices. This price disparity leads to erosion of market share and revenue for original branded products. The transition to generics intensifies pricing pressures, driving down profit margins and fragmenting the market with numerous similar products. Healthcare providers and insurers increasingly favor generics to reduce treatment costs, further impacting demand for branded therapies. For patients and dermatologists, a growing array of generic options can create confusion and complicate prescribing decisions. As the volume of generics increases, innovation may slow due to reduced financial incentives for R&D in new dermatological treatments, challenging companies to maintain competitiveness in a cost-sensitive environment.
Key Market Trends
Personalized Medicine
Personalized medicine is reshaping the landscape of dermatological therapeutics by offering targeted, individualized treatment approaches based on a patient's genetic profile, biomarkers, and disease characteristics. Advances in genomics enable the identification of genetic markers linked to specific skin conditions, such as psoriasis or melanoma, leading to tailored therapeutic interventions. Biomarker analysis allows dermatologists to predict patient responses to certain drugs and monitor disease progression more accurately. The use of biologics and small molecule inhibitors designed to target specific disease pathways has significantly improved outcomes for patients with severe dermatological conditions. Additionally, customized topical formulations-developed in collaboration with compounding pharmacies-address individual needs related to skin type and sensitivities. Personalized medicine also enhances risk stratification and prevention strategies for skin cancers and chronic inflammatory skin diseases. This trend is driving better clinical results, minimizing side effects, and marking a shift toward more effective and proactive dermatological care.
Key Market Players
- Abbvie Inc. (Allergan PLC)
- Almirall SA
- Amgen Inc.
- Bausch Health Companies Inc.
- Galderma SA
- GlaxoSmithKline PLC
- Johnson & Johnson
- Novartis AG
- Pfizer Inc.
- Bristol-Myers Squibb Company
Report Scope:
In this report, the Global Dermatological Therapeutics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
- Dermatological Therapeutics Market, By Application:
o Alopecia
o Herpes
o Psoriasis
o Rosacea
o Atopic Dermatitis
o Other
- Dermatological Therapeutics Market, By Drug Class:
o Anti-infectives
o Corticosteroids
o Anti-acne
o Calcineurin Inhibitors
o Retinoids
o Other
- Dermatological Therapeutics Market, By Region:
o North America
United States
Canada
Mexico
o Europe
France
United Kingdom
Italy
Germany
Spain
o Asia-Pacific
China
India
Japan
Australia
South Korea
o South America
Brazil
Argentina
Colombia
o Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Dermatological Therapeutics Market.
Available Customizations:
Global Dermatological Therapeutics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Dermatological Therapeutics Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Application (Alopecia, Herpes, Psoriasis, Rosacea, Atopic Dermatitis, Other)
5.2.2. By Drug Class (Anti-infectives, Corticosteroids, Anti-acne, Calcineurin Inhibitors, Retinoids, Other)
5.2.3. By Region
5.2.4. By Company (2024)
5.3. Market Map
6. North America Dermatological Therapeutics Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Application
6.2.2. By Drug Class
6.2.3. By Country
6.3. North America: Country Analysis
6.3.1. United States Dermatological Therapeutics Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Application
6.3.1.2.2. By Drug Class
6.3.2. Canada Dermatological Therapeutics Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Application
6.3.2.2.2. By Drug Class
6.3.3. Mexico Dermatological Therapeutics Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Application
6.3.3.2.2. By Drug Class
7. Europe Dermatological Therapeutics Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Application
7.2.2. By Drug Class
7.2.3. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Dermatological Therapeutics Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Application
7.3.1.2.2. By Drug Class
7.3.2. United Kingdom Dermatological Therapeutics Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Application
7.3.2.2.2. By Drug Class
7.3.3. Italy Dermatological Therapeutics Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Application
7.3.3.2.2. By Drug Class
7.3.4. France Dermatological Therapeutics Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Application
7.3.4.2.2. By Drug Class
7.3.5. Spain Dermatological Therapeutics Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Application
7.3.5.2.2. By Drug Class
8. Asia-Pacific Dermatological Therapeutics Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Application
8.2.2. By Drug Class
8.2.3. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Dermatological Therapeutics Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Application
8.3.1.2.2. By Drug Class
8.3.2. India Dermatological Therapeutics Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Application
8.3.2.2.2. By Drug Class
8.3.3. Japan Dermatological Therapeutics Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Application
8.3.3.2.2. By Drug Class
8.3.4. South Korea Dermatological Therapeutics Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Application
8.3.4.2.2. By Drug Class
8.3.5. Australia Dermatological Therapeutics Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Application
8.3.5.2.2. By Drug Class
9. South America Dermatological Therapeutics Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Application
9.2.2. By Drug Class
9.2.3. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Dermatological Therapeutics Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Application
9.3.1.2.2. By Drug Class
9.3.2. Argentina Dermatological Therapeutics Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Application
9.3.2.2.2. By Drug Class
9.3.3. Colombia Dermatological Therapeutics Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Application
9.3.3.2.2. By Drug Class
10. Middle East and Africa Dermatological Therapeutics Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Application
10.2.2. By Drug Class
10.2.3. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Dermatological Therapeutics Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Application
10.3.1.2.2. By Drug Class
10.3.2. Saudi Arabia Dermatological Therapeutics Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Application
10.3.2.2.2. By Drug Class
10.3.3. UAE Dermatological Therapeutics Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Application
10.3.3.2.2. By Drug Class
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Recent Developments
12.2. Product Launches
12.3. Mergers & Acquisitions
13. Global Dermatological Therapeutics Market: SWOT Analysis
14. Competitive Landscape
14.1. Abbvie Inc. (Allergan PLC)
14.1.1. Business Overview
14.1.2. Product & Service Offerings
14.1.3. Recent Developments
14.1.4. Financials (If Listed)
14.1.5. Key Personnel
14.1.6. SWOT Analysis
14.2. Almirall SA
14.3. Amgen Inc.
14.4. Bausch Health Companies Inc.
14.5. Galderma SA
14.6. GlaxoSmithKline PLC
14.7. Johnson & Johnson
14.8. Novartis AG
14.9. Pfizer Inc.
14.10.Bristol-Myers Squibb Company.
15. Strategic Recommendations
16. About Us & Disclaimer
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security